Evotec SE (EVO) Research & Development (2009 - 2025)
Evotec SE's (EVO) quarterly Research & Development came in at -$11.4 million in Q4 2025, down 10.04% year-over-year from -$12.7 million in Q4 2024, and down 12.31% quarter-over-quarter from -$10.2 million in Q3 2025.
Analysis
Evotec SE (EVO) Research & Development (2009 - 2025) Analysis & Trends
Evotec SE has disclosed Research & Development across 9 years of filings, most recently posting -$11.4 million for Q4 2025.
- In Q4 2025, Research & Development fell 10.04% year-over-year to -$11.4 million; the TTM figure through Dec 2025 stood at -$42.2 million (up 23.48% YoY), while the FY2025 annual figure was -$42.4 million, up 23.01% from the prior year.
- Research & Development came in at -$11.4 million for Q4 2025 at Evotec SE, down from -$10.2 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $21.3 million in Q3 2021 to a low of -$143.8 million in Q4 2021.
- Average Research & Development over 5 years is -$25.6 million, with a median of -$15.9 million recorded in 2024.
- Year-over-year, Research & Development decreased 12.4% in 2022 and soared 83.89% in 2023.
- Over 5 years, Research & Development stood at -$143.8 million in 2021, then gained by 6.35% to -$134.6 million in 2022, then soared by 83.89% to -$21.7 million in 2023, then jumped by 52.08% to -$10.4 million in 2024, then retreated by 10.04% to -$11.4 million in 2025.
- Per Business Quant data, the three most recent Research & Development figures were -$11.4 million in Q4 2025, -$10.2 million in Q3 2025, and -$9.3 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | - |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | - |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | - |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 46.21 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | 2.35 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 1.15 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | 1.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -11.44 Mn |
| Sep 30, 2025 | -10.19 Mn |
| Jun 30, 2025 | -9.29 Mn |
| Mar 31, 2025 | -11.32 Mn |
| Dec 31, 2024 | -10.40 Mn |
| Sep 30, 2024 | -13.04 Mn |
| Jun 30, 2024 | -14.11 Mn |
| Mar 31, 2024 | -17.64 Mn |
| Dec 31, 2023 | -21.69 Mn |
| Jun 30, 2023 | -20.13 Mn |
| Dec 31, 2022 | -134.63 Mn |
| Sep 30, 2022 | 18.63 Mn |
| Jun 30, 2022 | -19.98 Mn |
| Mar 31, 2022 | -20.33 Mn |
| Dec 31, 2021 | -143.77 Mn |
| Sep 30, 2021 | 21.27 Mn |
| Jun 30, 2021 | -20.44 Mn |
| Mar 31, 2021 | -22.27 Mn |
| Dec 31, 2020 | -131.18 Mn |
| Sep 30, 2020 | 19.02 Mn |